Anxiety Disorder in Conditions Classified Elsewhere Clinical Trial
Official title:
A Mindfulness-based Intervention for Treatment of Anxiety in ICD Patients
The purpose of this study is to evaluate the feasibility and preliminary efficacy of a mindfulness-based behavioral intervention combining breathing and other relaxation exercises on symptoms of anxiety in patients undergoing the implantation of an implantable cardioverter defibrillator. This study will pilot test the feasibility and preliminary efficacy of a mindfulness-based intervention intended to improve mindfulness and anxiety levels in ICD (Implantable Cardioverter Defibrillators) patients. A randomized controlled study design will be used, in which an 8 session phone-delivered mindfulness intervention will be compared to a usual care condition among consecutive candidates for ICD procedures. The study will be conducted at the Electrophysiology (EPS) Unit at the UMass Memorial Medical Center. Assessments will be performed at baseline and at the end of the intervention (9 weeks after enrollment).
| Status | Completed |
| Enrollment | 46 |
| Est. completion date | December 2011 |
| Est. primary completion date | December 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: 1. Age = 21 2. ICD procedure 3. Ability to understand and speak English 4. Access to a telephone Exclusion Criteria: 1. Inability or unwillingness to give informed consent 2. Signs of cognitive impairment (Blessed Orientation-Memory-Concentration (BOMS)scores >10) 3. New York Heart Association (NYHA) functional class>III, angina Canadian Cardiovascular Society(CCS) III and IV or clinically unstable 4. Awaiting coronary by-pass or heart transplantation 5. Co-morbid life threatening condition 6. Ongoing severe depression or psychosis |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | UMass Memorial Medical Center | Worcester | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| University of Massachusetts, Worcester | National Center for Complementary and Integrative Health (NCCIH) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Study feasibility | post-intervention (9 weeks after enrollment) | No | |
| Secondary | Hospital Anxiety and Depression (HAD) anxiety scores | baseline and post-intervention (9 weeks) | No | |
| Secondary | Five Factors of Mindfulness scores (FFM) | baseline and post-intervention (9 weeks) | No |